AllianceBernstein’s Qiagen QGEN Stock Holding History

AllianceBernstein’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-167,581	Closed	-$6.01M	–	3170
2019 Q4	$6.01M	Buy	+167,581	New	+$6.23M	﹤0.01%	1324

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AllianceBernstein's QGEN Position: Q2 2026 in Review

AllianceBernstein reduced its Qiagen (QGEN) stake by 1.8% in Q2 2026, selling an estimated $91.3K and leaving 136,002 shares worth $5.45M. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

AllianceBernstein first reported a position in QGEN in Q1 2017 and has held it in 38 quarters since. The position peaked at $90.1M in Q3 2019. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

AllianceBernstein held 136,002 shares of Qiagen worth $5.45M as of Q2 2026.
AllianceBernstein sold 2,457 Qiagen shares in Q2 2026, an estimated $91.3K.
Qiagen made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1495 holding.
AllianceBernstein first reported a position in Qiagen in Q1 2017 and has held it in 38 quarters since.
AllianceBernstein's Qiagen position peaked at $90.1M in Q3 2019.
337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.